HTB

EACS 12 Cologne 2009

12th European AIDS Society Conference (EACS), 11-14 November 2009, Cologne

Screening for anal cancer recommended for HIV positive men

Once-daily darunavir/r monotherapy is suboptimal as initial regimen in treatment-naive people

Central fat accumulation remains a significant problem in patients starting HAART after 2005 with higher incidence in women compared to men

Alendronate improves bone mineral density in HIV positive people with osteoporosis at 96 weeks

TMC278 did not show teratogenic potential in animal models

Etravirine pregnancy data from five cases: no dose adjustment required

No clinically relevant interactions between TMC278 and oral contraceptives (norethindrone plus ethinylestradiol)

Gender-based differences in patients receiving antiretroviral therapy

Pilot PK study of two generic paediatric formulations of lopinavir/ritonavir vs originator products

Other selected PK and drug interaction summaries from EACS

12th European AIDS Society Conference (EACS) 11-14 November 2009, Cologne

EACS releases three updated management guidelines (December 2009)